<DOC>
	<DOCNO>NCT01721642</DOCNO>
	<brief_summary>A pilot study evaluate safety efficacy Apica Access , Stabilization , Closure Device access closing leave ventricular apex Transcatheter Aortic Valve Implantation ( TAVI ) procedure . Follow-up assessment make post-procedure , 30 day 90 day well long term follow-up .</brief_summary>
	<brief_title>A Pilot Study Evaluate Safety Efficacy Apica Access , Stabilization Closure ( ASC™ ) Device</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Subject age ≥ 18 year age . Subjects select accordance investigate center standard operating procedure TAVI subject selection treatment . Subjects select meet TAVI inclusion criterion follow : Subject Senile degenerative aortic stenosis echocardiography derive criterion : mean gradient &gt; 40 mm Hg jet velocity &gt; 4.0 m/s aortic valve area ( AVA ) &lt; 0.8 cm2 ( AVA index &lt; 0.5 cm2/m2 . Subject symptomatic due aortic valve stenosis demonstrate NYHA Functional Class &gt; II . Additive EuroScore &gt; 9 Aortic annulus diameter &gt; 21mm &lt; 27mm TEE The subject subject 's legal representative inform nature study , agree provision provide write informed consent . The subject treating physician agree subject return require postprocedure followup visit . The subject , formal consults cardiologist two cardiovascular surgeon agree medical factor preclude operation , base conclusion probability death serious , irreversible morbidity exceed probability meaningful improvement . Specifically probability death serious , irreversible morbidity exceed 50 % . Subjects select accordance investigate center standard operating procedure TAVI subject selection treatment . The following TAVI exclusion criterion shall apply : Evidence acute myocardial infarction &lt; 1 month intend treatment Aortic valve congenital unicuspid bicuspid valve ; noncalcified Mixed aortic valve disease ( aortic stenosis aortic regurgitation predominant aortic regurgitation &gt; 3+ ) Preexisting prosthetic heart valve position , prosthetic ring , severe ( great 3+ ) mitral insufficiency Blood dyscrasia define : Leukopenia , acute anemia , thrombocytopenia , history bleed diathesis coagulopathy . Untreated clinically significant coronary artery disease require revascularization Hemodynamic instability require inotropic therapy mechanical hemodynamic support device Need emergency surgery reason Hypertrophic cardiomyopathy without obstruction Echocardiographic evidence intracardiac mass , thrombus vegetation Active peptic ulcer upper gastrointestinal bleeding within prior 3 month A know hypersensitivity contraindication asprin , heparin , ticlopidine ( Ticlid ) , clopidogrel ( Plavix ) , sensitivity contrast medium , adequately premedicated Recent ( within 6 month ) cerebrovascular accident transient ischemic attack Renal insufficiency and/or end stage renal disease require chronic dialysis . Life expectancy &lt; 12 month due noncardiac comorbid condition . The following ASC device exclusion criterion shall apply : Subjects &lt; 10mm Left ventricular wall thickness apical access site LVEF &lt; 30 % Subject previous DOR procedure Subject access site le 2 cm square `` fat '' free area visual observation Subject know Allergy hypersensitivity Titanium Subject require MR Imaging post procedure Subject Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>access</keyword>
	<keyword>closure</keyword>
	<keyword>trans-apical</keyword>
	<keyword>trans-catheter aortic valve implantation</keyword>
	<keyword>TAVI</keyword>
	<keyword>trans-catheter aortic valve repair</keyword>
	<keyword>TAVR</keyword>
</DOC>